This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Quality in terms of number of defective items, packaging and labelling, quality management system certification, research, development, and innovation. Services, such as customer relationship management (CRM), and after-sales service. Geographical location for timely delivery.
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, businessdevelopment managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
Packaging. • Test method development. The information contained within the download document is intended for pharmacists, pharmaceutical executives, sales managers, manufacturers, businessdevelopment managers, pharmaceutical sales representatives, and any other individual involved in the pharmaceutical compounding sector.
Amazon’s Launchpad program empowers and accelerates start-up businesses that will sell their products amazon.com. The program used to be an invitation-only service but recently, small Amazon sellers that make less than $5 million in gross sales can join the program by applying. .
We also look forward to welcoming Sporogenics to JLABS @ Shanghai,” said Peter Hawkes, Head of BusinessDevelopment, Medical Devices Asia Pacific, Johnson & Johnson. “At MAV participated in the MedTech Innovator Asia Pacific Accelerator program. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed.
Within global external innovation the pharma, medical devices and consumer health businesses of Johnson and Johnson share the mission to innovate to transform health for humanity.
Its specialized project marketplace, known as PartnerMatch, serves as an effective tool for stakeholders on both the supply and demand sides, enabling them to locate partners and enhance collaboration within the globally expansive consumer packaged goods market, valued in the trillions.
Revenue growth was 12 percent when excluding effects of 2020 COVID-related stocking patterns, revenue from COVID-19 antibodies and recent businessdevelopment. BusinessDevelopment/Other Developments. million of revenue associated with the sale of its rights to Cialis ® in China. Excluding $148.9
Product sales increased 3% globally, driven by double digit volume growth across a number of our products including Prolia ® (denosumab), Repatha ® (evolocumab) and our biosimilar products MVASI ® (bevacizumab-awwb) and KANJINTI ® (trastuzumab-anns). Product Sales Performance. Key results include: Total revenues increased 5% to $6.5
The information contained within the download document is intended for pharmaceutical executives, sales managers, manufacturers, businessdevelopment managers, technicians, freeze-dry operators, freeze-dryer market managers, refrigeration project engineers, packaging and inventory management associates, research associates, and any other individual (..)
net sales increased 11% to $1.32 Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07 “This is evidenced by Dupixent achieving in excess of $1 billion in global net sales this quarter.” Corporate and BusinessDevelopment Update. TARRYTOWN, N.Y. ,
NEW YORK–( BUSINESS WIRE )– Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and robust operating performance. chairman and chief executive officer, Bristol Myers Squibb.
The demerger structure reflects feedback from a significant proportion of GSK’s shareholders that they wish to own Consumer Healthcare as a new listed entity, given its strong prospects for sustainable sales and profit growth, high cash generation and the expectation that it will deliver attractive returns for shareholders.
Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through businessdevelopment activities.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content